Keryx Biopharmaceuticals Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 189

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.3B

Keryx Biopharmaceuticals General Information

Description

Operator of a biopharmaceutical company focused on bringing innovative medicines to people with renal disease. The company is focused on the development and commercialization of medicines that provide unique and meaningful advantages to people with renal disease and their healthcare providers.

Contact Information

Website
www.keryx.com
Formerly Known As
Keryx Biophamaeuticals Inc
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • One Marina Park Drive
  • Twelfth Floor
  • Boston, MA 02210
  • United States
+1 (617)
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Acquirer
Akebia Therapeutics
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • One Marina Park Drive
  • Twelfth Floor
  • Boston, MA 02210
  • United States
+1 (617)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Keryx Biopharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 13-Dec-2018 $1.3B Completed Generating Revenue
6. Convertible Debt 27-May-2016 Completed Generating Revenue
5. 2PO 12-May-2014 Completed Generating Revenue
4. PIPE 22-Jan-2013 Completed Generating Revenue
3. PIPE 18-Nov-2003 Completed Generating Revenue
2. IPO 27-Jul-2000 Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view Keryx Biopharmaceuticals’s complete valuation and funding history, request access »

Keryx Biopharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company focused on bringing innovative medicines to people with renal disease. The compa
Pharmaceuticals
Boston, MA
189 As of 2018

Bala Cynwyd, PA
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Keryx Biopharmaceuticals Competitors (65)

One of Keryx Biopharmaceuticals’s 65 competitors is Larimar Therapeutics, a Formerly VC-backed company based in Bala Cynwyd, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Larimar Therapeutics Formerly VC-backed Bala Cynwyd, PA
Agios Pharmaceuticals Formerly VC-backed Cambridge, MA
Sarepta Therapeutics Formerly VC-backed Cambridge, MA
Zynerba Pharmaceuticals Formerly VC-backed Plymouth, PA
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
You’re viewing 5 of 65 competitors. Get the full list »

Keryx Biopharmaceuticals Patents

  • 76

    Total Documents Applications and Grants

  • Total Patents Families

  • 18

    Granted

  • 12

    Pending

  • Expiring in next 12 mo

Keryx Biopharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4347022-A1 Pediatric formulations of ferric citrate Pending 27-May-2021
US-20240100011-A1 Pediatric formulations of ferric citrate Pending 27-May-2021
AU-2016226250-A1 Use of ferric citrate in the treatment of iron-deficiency anemia Active 04-Mar-2015
AU-2016226250-B2 Use of ferric citrate in the treatment of iron-deficiency anemia Inactive 04-Mar-2015
CA-2978073-A1 Use of ferric citrate in the treatment of iron-deficiency anemia Inactive 04-Mar-2015 A61K31/295
To view Keryx Biopharmaceuticals’s complete patent history, request access »

Keryx Biopharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Keryx Biopharmaceuticals Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alpha Capital Partners PE/Buyout Minority
Foresite Capital Growth/Expansion Minority
Great Point Partners PE/Buyout Minority
Kearny Venture Partners Venture Capital Minority
ProQuest Investments Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Keryx Biopharmaceuticals Investments & Acquisitions (2)

Keryx Biopharmaceuticals’s most recent deal was a Corporate Asset Purchase with Ausam Biotechnologies (Diagnostic Assets) for . The deal was made on 06-Apr-2006.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Ausam Biotechnologies (Diagnostic Assets) 06-Apr-2006 Corporate Asset Purchase Buildings and Property
Access Oncology 05-Feb-2004 Merger/Acquisition Biotechnology
To view Keryx Biopharmaceuticals’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

Keryx Biopharmaceuticals ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Keryx Biopharmaceuticals’s complete esg history, request access »

Keryx Biopharmaceuticals FAQs

  • When was Keryx Biopharmaceuticals founded?

    Keryx Biopharmaceuticals was founded in 1997.

  • Where is Keryx Biopharmaceuticals headquartered?

    Keryx Biopharmaceuticals is headquartered in Boston, MA.

  • What is the size of Keryx Biopharmaceuticals?

    Keryx Biopharmaceuticals has 189 total employees.

  • What industry is Keryx Biopharmaceuticals in?

    Keryx Biopharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Keryx Biopharmaceuticals a private or public company?

    Keryx Biopharmaceuticals is a Private company.

  • What is the current valuation of Keryx Biopharmaceuticals?

    The current valuation of Keryx Biopharmaceuticals is .

  • What is Keryx Biopharmaceuticals’s current revenue?

    The current revenue for Keryx Biopharmaceuticals is .

  • How much funding has Keryx Biopharmaceuticals raised over time?

    Keryx Biopharmaceuticals has raised $140M.

  • Who are Keryx Biopharmaceuticals’s investors?

    Alpha Capital Partners, Foresite Capital, Great Point Partners, Kearny Venture Partners, and ProQuest Investments are 5 of 9 investors who have invested in Keryx Biopharmaceuticals.

  • Who are Keryx Biopharmaceuticals’s competitors?

    Larimar Therapeutics, Agios Pharmaceuticals, Sarepta Therapeutics, Zynerba Pharmaceuticals, and Adaptimmune Therapeutics are some of the 65 competitors of Keryx Biopharmaceuticals.

  • When was Keryx Biopharmaceuticals acquired?

    Keryx Biopharmaceuticals was acquired on 13-Dec-2018.

  • Who acquired Keryx Biopharmaceuticals?

    Keryx Biopharmaceuticals was acquired by Akebia Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »